SLC27A2 and neoplasm: Conversely, when PMN-MDSCs themselves undergo ferroptosis in the tumor microenvironment, they release lipid oxides via fatty acid transporter (FATP2)-mediated pathways, creating an immunosuppressive niche that paradoxically supports tumor progression.